Literature DB >> 18829767

Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids.

Patricia M Day1, Douglas R Lowy, John T Schiller.   

Abstract

Papillomavirus infection normally involves virion binding to cell surface heparan sulfate proteoglycans (HSPGs). However, we found that human papillomavirus type 16 pseudovirions efficiently bound and infected cells lacking HSPGs if their L2 capsid protein was precleaved by furin, a cellular protease required for infection. The inability of pseudovirions to efficiently bind and infect cultured primary keratinocytes was also overcome by furin precleavage, suggesting that the defect involves altered HSPG modification. We conclude that the primary function of HSPG binding is to enable cell surface furin cleavage of L2 and that binding to a distinct cell surface receptor(s) is a subsequent step of papillomavirus infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829767      PMCID: PMC2593329          DOI: 10.1128/JVI.01631-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Human papillomavirus infection requires cell surface heparan sulfate.

Authors:  T Giroglou; L Florin; F Schäfer; R E Streeck; M Sapp
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 2.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription.

Authors:  Michelle A Ozbun
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis.

Authors:  F N Lugemwa; J D Esko
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

5.  Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  James M Binley; Rogier W Sanders; Aditi Master; Charmagne S Cayanan; Cheryl L Wiley; Linnea Schiffner; Bruce Travis; Shawn Kuhmann; Dennis R Burton; Shiu-Lok Hu; William C Olson; John P Moore
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates.

Authors:  D J Pearton; W Nirunsuksiri; A Rehemtulla; S P Lewis; R B Presland; B A Dale
Journal:  Exp Dermatol       Date:  2001-06       Impact factor: 3.960

7.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

Review 8.  The activation and physiological functions of the proprotein convertases.

Authors:  Nabil G Seidah; Gaetan Mayer; Ahmed Zaid; Estelle Rousselet; Nasha Nassoury; Steve Poirier; Rachid Essalmani; Annik Prat
Journal:  Int J Biochem Cell Biol       Date:  2008-02-08       Impact factor: 5.085

9.  LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome.

Authors:  Emmanuelle Bitoun; Alessia Micheloni; Laurence Lamant; Chrystelle Bonnart; Alessandro Tartaglia-Polcini; Christian Cobbold; Talal Al Saati; Feliciana Mariotti; Juliette Mazereeuw-Hautier; Franck Boralevi; Daniel Hohl; John Harper; Christine Bodemer; Marina D'Alessio; Alain Hovnanian
Journal:  Hum Mol Genet       Date:  2003-07-29       Impact factor: 6.150

10.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.

Authors:  K R Klimpel; S S Molloy; G Thomas; S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more
  89 in total

1.  Structural basis of oligosaccharide receptor recognition by human papillomavirus.

Authors:  Jhimli Dasgupta; Malgorzata Bienkowska-Haba; Marcos E Ortega; Hetalkumar D Patel; Sabrina Bodevin; Dorothe Spillmann; Brooke Bishop; Martin Sapp; Xiaojiang S Chen
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

2.  Human papillomavirus capsids preferentially bind and infect tumor cells.

Authors:  Rhonda C Kines; Rebecca J Cerio; Jeffrey N Roberts; Cynthia D Thompson; Elisabet de Los Pinos; Douglas R Lowy; John T Schiller
Journal:  Int J Cancer       Date:  2015-10-27       Impact factor: 7.396

3.  A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.

Authors:  Patricia M Day; Yuk-Ying S Pang; Rhonda C Kines; Cynthia D Thompson; Douglas R Lowy; John T Schiller
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

4.  Human keratinocyte cultures in the investigation of early steps of human papillomavirus infection.

Authors:  Laura M Griffin; Louis Cicchini; Tao Xu; Dohun Pyeon
Journal:  Methods Mol Biol       Date:  2014

5.  Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.

Authors:  Katherine M Johnson; Rhonda C Kines; Jeffrey N Roberts; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 6.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

Review 7.  Papillomavirus prophylactic vaccines: established successes, new approaches.

Authors:  M Saveria Campo; Richard B S Roden
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Target cell cyclophilins facilitate human papillomavirus type 16 infection.

Authors:  Malgorzata Bienkowska-Haba; Hetalkumar D Patel; Martin Sapp
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

9.  Role of L2 cysteines in papillomavirus infection and neutralization.

Authors:  Ratish Gambhira; Subhashini Jagu; Balasubramanyam Karanam; Patricia M Day; Richard Roden
Journal:  Virol J       Date:  2009-10-27       Impact factor: 4.099

Review 10.  Cellular receptor binding and entry of human papillomavirus.

Authors:  Tan Letian; Zhang Tianyu
Journal:  Virol J       Date:  2010-01-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.